Archive for Urology News



Page 11234..1020..»


EAU Issues Updated UTUC Guidelines – Renal and Urology News

The European Association of Urology (EAU) has updated its 2017 guidelines on upper tract urothelial carcinoma (UTUC) based on a review of the latest evidence. Here are some key recommendations from the guidelines, which were published in European Urology by Morgan Rouprt, MD, of Sorbonne University in Paris, France, and colleagues. Lynch syndrome and exposure to aristolochic acid or smoking all increase the risk for UTUC.

Read More..

AVEO Oncology Announces European Urology Publication of Final Overall Survival Data from Phase 3 TIVO-3 Study of Tivozanib in Renal Cell Carcinoma -…

AVEO Oncology (Nasdaq: AVEO) today announced that final overall survival (OS) results from its Phase 3 TIVO-3 study were published in the journal European Urology. TIVO-3 is the Companys pivotal Phase 3 trial comparing tivozanib, AVEOs next-generation vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor (TKI) drug candidate, to sorafenib in third and fourth line renal cell carcinoma (RCC). The article, titled "Final Overall Survival Results from a Phase 3 Study to Compare Tivozanib to Sorafenib as Third- or Fourth-line Therapy in Subjects with Metastatic Renal Cell Carcinoma," is available online first via this link

Read More..

Nephrology and Urology Devices Market to Witness Exponential Growth by 2020-2027 | Leading Players Nikkiso Co.Ltd., Fresenius Medical Care AG &…

Fort Collins, Colorado The report on the Nephrology and Urology Devices Market provides an in-depth assessment of the Nephrology and Urology Devices market including technological advancements, market drivers, challenges, current and emerging trends, opportunities, threats, risks, strategic developments, product advancements, and other key features.

Read More..

Choyce Peterson, Exclusive Listing Agent for 623 Newfield Avenue in Stamford, Successfully Leases Building to Hartford HealthCare Corporation – WFMZ…

NORWALK, Conn., Sept. 17, 2020 /PRNewswire/ --Choyce Peterson, Inc

Read More..

Darolutamide Prolongs Overall Survival in nmCRPC – Renal and Urology News

Darolutamide prolongs overall survival for patients with nonmetastatic castration-resistant prostate cancer (nmCRPC), according to a final analysis of the phase 3 Androgen Receptor Antagonizing Agent for Metastasis-Free Survival trial (ARAMIS; NCT02200614). An interim analysis conducted in 2019 confirmed longer metastasis-free survival. Overall survival at 3 years was 83% among darolutamide-treated patients compared with 77% among placebo-treated patients

Read More..

Scoping review: hotspots for COVID-19 urological research: what is being published and from where? – DocWire News

This article was originally published here World J Urol. 2020 Sep 9

Read More..

Ann French is Urology Nurse of the Year | Gazette – Gazette

A NURSE from Colchester has been named the best in Britain in her field after scooping a prestigious award. Ann French, has been in the profession for more than 40 years, and has now been named the Urology Nurse of the Year at the British Journal of Nursing (BJN) Awards.

Read More..

Preliminary assessment of patient and physician satisfaction with the use of teleconsultation in urology during the COVID-19 pandemic – DocWire News

This article was originally published here World J Urol. 2020 Sep 9.

Read More..

Higher Microbial Diversity May Be Associated with Better Outcomes in Patients with RCC – Cancer Network

A comparison of the composition and diversity of the gut microbiome in patients receiving immunotherapy for metastatic renal cell carcinoma (RCC) found that higher microbial diversity is associated with better treatment outcomes in this patient population.1 The results, published in European Urology, also found that treatment response is characterized by shifts in microbial species over the course of treatment. Previous studies have suggested a relationship between the gut microbiome and response to immunotherapy in solid tumors, including metastatic kidney cancer, lead author Nicholas Salgia, BSc,a clinical research assistant at City of Hope, said in a press release.2 The results from our study build on earlier findings and reaffirm that the diversity and composition of patients microbiomes are associated with clinical responses to anti-cancer therapies. In order to characterize the stool microbiome of patients with metastatic RCC receiving a checkpoint inhibitor, researchers collected stool from 31 patients before initiation of nivolumab (77%) or nivolumab plus ipilimumab (23%) therapy; 58% of these patients experienced clinical benefit.

Read More..

Urinary Catheters Market worth $2.6 billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

CHICAGO, Sept.

Read More..

The daily huddle: The best two minutes you can spend with your staff – Medical Economics

Why physicians should consider a daily huddle to boost staff efficiency and hit practice goals. Why physicians should consider a daily huddle to boost staff efficiency and hit practice goals

Read More..

Prostate Cancer Care Rebounding After COVID-19 Disruption – Renal and Urology News

Routine and nonessential healthcare services came to a nearly complete halt in many places throughout the United States as a result of the coronavirus disease 2019 (COVID-19) pandemic.

Read More..

Am I going to the toilet too often? | News and Star – News & Star

Urology Specialist Nurse Sister Helen Lanka at North Cumbria Integrated Care NHS Foundation Trust explains what signs people should look out for if they are experiencing urological problems. She said: Men and woman are different when it comes to their water works. "For example, men have something called a prostate which lives underneath the bladder which the urethra (urine pipe), passes through.

Read More..

Urology Care Foundation Announces Recipient of the 2020 Rising Stars in Urology Research Award – WFMZ Allentown

BALTIMORE, Aug. 25, 2020 /PRNewswire/ -- The American Urological Association (AUA) and the Urology Care Foundationthe official foundation of the AUAtoday announced Simpa Salami, MD, MPH as the recipient of the 2020 Rising Stars in Urology Research Award. Dr

Read More..

August: UNBLOCS study | News and features – University of Bristol

25 August 2020 New research has shown two procedures to treat men with an enlarged prostate gland are both effective. The trial compared the current gold standard treatment of TURP (Transurethral Resection of the Prostate) to a laser technique called ThuVARP (Thulium Laser Transurethral Vaporesection of the Prostate). The study led by the Bristol Urological Institute, a world renowned centre for urological research and urodynamics, at North Bristol NHS Trust, funded by a 1.2 million grant from the National Institute for Health Research (NIHR) and managed by the Bristol Trials Centre, is published in The Lancet

Read More..

Urology Lasers Market Report, History And Forecast 2020-2025, Breakdown Data By Manufacturers, Key Regions, Types And Application – Scientect

A new research study has been presented by UpMarketResearch.com offering a comprehensive analysis on the Global Urology Lasers Market where user can benefit from the complete market research report with all the required useful information about this market. This is a latest report, covering the current COVID-19 impact on the market

Read More..

Priorities in Prostate Cancer Care During the Pandemic – Renal and Urology News

During the COVID-19 pandemic, urologists caring for patients with prostate cancer (PCa) have needed to weigh the benefits of routine care against the potential risks for viral spread. In Prostate Cancer and Prostatic Diseases, Tunkut Doganca, MD, of Acibadem Taksim Hospital in Istanbul, Turkey, and colleagues compiled and discussed current guidance to prevent the spread of COVID-19 among patients with PCa and their healthcare team

Read More..

Study Validates 3-Tiered Subclassification of High-Risk Prostate Cancer – Renal and Urology News

Investigators have validated the prognostic utility of a 3-tiered subclassification of high-risk prostate cancer (PCa) in patients treated with radical prostatectomy (RP), according to a new report. These findings may help tailor treatment decision-making for men with favorable high-risk or very high-risk disease, potentially allow for more efficient clinical trial design, and help tailor the use of advanced imaging in the pre-operative evaluation of patients with unfavorable-risk prostate cancer, investigators led by Vinayak Muradlidhar, MD, MSc, of the Harvard Radiation Oncology Program in Boston, Massachusetts, reported in Urology.

Read More..

Antares Supports Lee Equity Partners’ Acquisition of Integrated Medical Professionals and The Urology Group to Form Solaris Health – Business Wire

CHICAGO--(BUSINESS WIRE)--Antares announced today that it served as lead arranger and is acting as administrative agent on senior secured credit facilities to support the acquisition of Integrated Medical Professionals (IMP) and The Urology Group (TUG) by Lee Equity Partners to form Solaris Health.

Read More..

Guidewires Market Analysis Highlights the Impact of COVID-19 (2020-2024) | Prevalence of Chronic Disorders to boost the Market Growth | Technavio -…

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the guidewires market and it is poised to grow by USD 656.92 million during 2020-2024, progressing at a CAGR of about 6% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment

Read More..

Medtronic Begins Post-Market, Real-World Study of the InterStim Micro System – GlobeNewswire

ELITE Study Designed to Confirm Long-Term Safety, Efficacy and Patient Benefit of Sacral Neuromodulation with the InterStim Micro System for Treatment of Overactive Bladder, Fecal Incontinence and Non-Obstructive Urinary Retention DUBLIN, Aug. 20, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has begun recruitment of the prospective, multicenter, global, post-market study of the InterStim Micro system for sacral neuromodulation (SNM) therapy. Medtronicannounced approvalfrom the U.S

Read More..

Butterfly Infusion Sets Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: B. Braun, Advin Urology, Medline, Vogt…

Latest Butterfly Infusion Sets Market report evaluates the impact of Covid-19 outbreak on the industry, involving potential opportunity and challenges, drivers and risks and market growth forecast based on different scenario. Global Butterfly Infusion Sets industry Market Report is a professional and in-depth research report on the worlds major regional market

Read More..

Urology Lasers Market share forecast to witness considerable growth from 2020 to 2025 | By Top Leading Vendors Gigaa Laser, Hyper Photonics, Jena…

Latest Research Report: Urology Lasers industry Urology Lasers Market report is to provide accurate and strategic analysis of the Profile Projectors industry. The report closely examines each segment and its sub-segment futures before looking at the 360-degree view of the market mentioned above.

Read More..

Shipman Partners With East Hawaii Health Clinic To Expand Keaau Services – Big Island Video News

(BIVN) A blessing was held on Wednesday at the former W.H. Shipman headquarter building, which will now house the East Hawaii Health Clinic Keaau. From a joint media release from W.H.

Read More..

Global Laser Therapy Market Forecasts to 2027 with COVID-19 Impact Analysis by Type, Application, End-user and Geography – ResearchAndMarkets.com -…

DUBLIN--(BUSINESS WIRE)--The "Laser Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering. The global laser therapy market is expected to reach US$ 3,514.02 million by 2027 from US$ 1,665.65 million in 2019; it is estimated to grow at a CAGR of 9.9% during 2020-2027

Read More..